Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha- Synuclein PMCA
AssigneeBoard of Regents, The University of Texas System
InventorsClaudio Soto Jara, Mohammad Shahnawaz
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsClaudio Soto Jara, Mohammad Shahnawaz
Estimating the term…
A method is provided for distinguishing between and/or diagnosing Parkinson's disease (PD) or multiple system atrophy (MSA) in a subject who is exhibiting symptoms associated with both PD and MSA. The method comprises: (A) contacting a biological sample obtained from the subject and comprising soluble, misfolded alpha-synuclein (αS) protein with a pre-incubation mixture comprising a monomeric αS substrate and an indicator to form an incubation mixture; (B) conducting an incubation cycle two or more times on the incubation mixture to form misfolded αS aggregates; (C) subjecting the incubation mixture to excitation and detecting via indicator fluorescence emission the misfolded αS aggregates; and (D) diagnosing the subject has having PD or MSA depending on the fluorescence emission intensity. In some aspects, the incubation cycles are conducted in the presence of a bead.
A method for differentiating a diagnosis of Parkinson's Disease (PD) from a diagnosis of Multiple System Atrophy (MSA) in a human subject, the method comprising:
A method for differentiating a diagnosis of PD from a diagnosis of MSA in a human subject, the method comprising:
A method for differential diagnosis of PD from MSA in a human subject, the method comprising:
Dependencies are inferred from the claim text.